Tag: UCL

Latest articles

Merck discontinues development of its two COVID-19 vaccines

Merck discontinues development of its COVID-19 vaccines

Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...
COVID-19 vaccination programme ramps up with 30 new centres

COVID-19 vaccination programme ramps up with 30 new centres

More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Isle of Man set to become world-leading exporter of medicinal cannabis

Isle of Man set to become world-leading exporter of medicinal cannabis

The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...

Popular articles

Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
JCVI updates priority list for COVID-19 vaccine

JCVI updates priority list for COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Merck discontinues development of its two COVID-19 vaccines

Merck discontinues development of its COVID-19 vaccines

Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription